Pharmaceutical company AstraZeneca is beginning a clinical trial in collaboration with Quintiles looking at the impact of mobile medication reminders for people with chronic obstructive pulmonary ...
FILE - The logo for Merck appears above a trading post on the floor of the New York Stock Exchange, Thursday, May 1, 2025. (AP Photo/Richard Drew, File) (Richard Drew ...
New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma’s new chronic ...
Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback